March 09, 2012
Eli Lilly & Co. on Friday ended its New Jersey federal court suit against Zydus Pharmaceuticals USA Inc. as the companies reached an agreement resolving Eli Lilly's claims that the generics maker infringed its patented attention deficit hyperactivity disorder drug.
May 09, 2011
Eli Lilly & Co. slapped Zydus Pharmaceuticals USA Inc. with a patent infringement suit Thursday in New Jersey, accusing it of breaching a consent order entered in a previous case Lilly brought over attention deficit hyperactivity disorder treatment Strattera.